Hidradenitis Suppurativa (HS)
Dealing with Hidradenitis Suppurativa (HS) can be tough—the flare-ups, the lack of understanding, the explanations. But you could be part of the research for a potential new treatment. The purpose of our clinical research trial is to evaluate the safety and effectiveness of an investigational medication for people with moderate to severe HS.
Study site: Encore Medical Research
- Hidradenitis suppurativa (HS)
Recruiting
Male/Female
18 - 70 years of age
Compensation Provided
- About the Study
- The purpose of this clinical research trial is to evaluate the safety and effectiveness of an investigational medication for people with moderate to severe HS.
- What does the study involve?
- The study will last for 7 weeks, and require 2 visits to the office per week.
- Who can participate?
- You must be between 18 and 70 years of age and have had signs/symptoms of Hidradenitis Suppurativa for a minimum of one year. You must also have HS bumps or lesions on at least 2 different parts of your body and have had an inadequate response to at least a 3-month treatment with an oral antibiotic taken for your HS.
- Is compensation provided?
- Yes: Up to $2300 for taking part.
Where is the study taking place?
Hollywood
Weston
Boynton Beach
One moment…
About Encore Medical Research
Encore Medical Research has been serving the South Florida Community since 2017 focusing on phases II through IV clinical trials. Our goal is to provide the highest standard of care to our patients while delivering unmatched performance in our research operations.